Stockholm - Delayed Quote SEK

Qlife Holding AB (publ) (QLIFE.ST)

Compare
2.4200 0.0000 (0.00%)
At close: October 25 at 4:32 PM GMT+2

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
NameTitlePayExercisedYear Born
Mr. Thomas Warthoe Co-Founder, CEO & Director 1.88M -- 1967
Mr. Peter Warthoe Co-Founder & Chief Scientific Officer -- -- 1967
Peter Thorsen Chief Financial Officer -- -- --

Qlife Holding AB (publ)

Redaregatan 48
Helsingborg, 252 36
Sweden
45 21 63 35 34 https://www.qlifeholding.com
Sector:?
Healthcare
Industry:?
Medical Devices
Full Time Employees:?
7

Description

Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents. The company offers Egoo.Health Platform, an integrated platform with a measuring instrument with disposable capsules and software, where each capsule contains a test for a specific biomarker or virus. Its biomarkers include C-reactive protein, PHE/Phenylalanine for PKU patients, and Sars-CoV-2/Influenza multiplex tests. The company was incorporated in 2019 and is based in Helsingborg, Sweden.

Corporate Governance

Qlife Holding AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers